WHO Considerations for Shigella vaccine development
|
|
- Arnold Maxwell
- 5 years ago
- Views:
Transcription
1 WHO Cnsideratins fr Shigella vaccine develpment WHO s 2018 Prduct Develpment fr Vaccines Advisry Cmmittee meeting: A year in review BMGF Shigella Internatinal ELISA and Standards Wrkshp Birgitte Giersing, PhD Initiative Birgitte K. Giersing fr Vaccine Lndn 5 Research, December 2017 WHO 26 th June 2018
2 What des PDVAC d? PDVAC s missin is t accelerate prduct develpment f vaccines and technlgies that are urgently needed and ensure they are apprpriately targeted fr use in lw and middle incme cntexts. Vaccine candidates Mnclnal antibdies Delivery technlgies
3 What des PDVAC d? Hrizn scanning f vaccine in early clinical develpment Evaluates prbability f technical and regulatry success and a rle fr WHO Unmet public health need fr a vaccine frm an LMIC perspective and cmmunicate pririties
4 What is the prblem we are trying t slve? Prduct Prduct Translatin gap Launch Implementatin gap Intrductin Discvery Preclinical Phase I-III Registratin WHO plicy & PQ Implementatin studies Financing & Prcurement Uptake
5 Hw des PDVAC wrk? Preferred prduct characteristics and the glbal preferred prduct prfile describe vaccine preferences Pathgen-specific guidance fr LMIC use PPC: Indicatin, target ppulatin, schedule, efficacy target, rute f admin. gppp: Frmulatin, primary cntainer, packaging Radmaps and pathway cnsultatins facilitate hw t achieve PPCs Cnsideratins fr prduct develpment pathways Vaccine radmap Develped by PDVAC Develped by Vaccine Presentatin and Packaging Advisry Grup (VPPAG)
6 WHO PPCs seek t braden the scpe f Target prduct prfiles (TPPs)* t incrprate LMIC market Parameter WHO PPC TPP Fcus Pathgen-specific Candidate (prduct) specific Cntent Audience Describes preferences fr LMICs Any entity seeking eventual PQ/LMIC market Sets minimal criteria fr develpment Stakehlders interested in return n investment Pathgen-specific guidance fr LMIC use PPC gppp PPCs infrm Candidate Specific target prduct prfiles (TPPs) TPP Purpse Encurage innvatin, braden vaccine target ppulatins Guide investment decisin making Prcess f develpment Public health stakehlder cnsultatin Within institutins * TPPs are develped by ther stakehlders and entities, typically private industry
7 Full Public Health Value Prpsitins (FPHVP)* fr Vaccines Meeting f the Strategic Advisry Grup f Experts (SAGE) n Immunizatin, Geneva, April TITLE frm VIEW and SLIDE MASTER July 19, 2018
8 Full Public Health Value Prpsitins (FPHVP)* fr Vaccines Meeting f the Strategic Advisry Grup f Experts (SAGE) n Immunizatin, Geneva, April 2018 *Full public health value f vaccines (FPHVV) 8 TITLE frm VIEW and SLIDE MASTER July 19, 2018
9 What is the prblem we are trying t slve? Prduct Prduct Translatin gap Launch Implementatin gap Intrductin Discvery Preclinical Phase I-III Registratin WHO plicy & PQ Implementatin studies Financing & Prcurement Uptake Articulating the public health value, PPCs, radmaps early in prduct develpment help t define the value prpsitin, encurage investment and mitigate against the implementatin gap
10 Human Immundeficiency virus (HIV) Tw HIV vaccine candidates are currently in late stage clinical trials in HIV-uninfected ppulatins, as heterlgus prime-bst appraches. mab als in late stage. Data anticipated in PDVAC recmmendatin: Facilitate scenari planning and develpment f cmmunicatin strategies in preparatin fr HIV vaccine and mnclnal antibdy study utcmes. Evaluate the develpment pathway beynd nging prf-f-cncept studies. Identify gaps in guidelines t supprt licensure, availability and use in LMICs February 2018: Frm prf f efficacy t plicy decisin, access and use f prduct fr passive and active immunizatin t prevent HIV infectin: Prepare fr Success
11 Tuberculsis (TB) Primary strategic public health gal: reductin f disease in adlescents and adults Seven tuberculsis vaccine candidates in phase II clinical studies, and ne in phase III PDVAC recmmendatin: Cntinue t facilitate and seek t accelerate develpment f vaccines fr preventin f tuberculsis in adults and adlescents Develpment f a PPC fr this indicatin. Octber 2017: WHO Initiative fr Vaccine Research & Glbal Tuberculsis Prgram Cnsultatin n Tuberculsis Vaccine Research and Develpment PPC published
12 Malaria Prgress twards start f RTS,S/AS01 pilt implementatin studies Fractinal RTS,S/AS01 dse regimen with ptential fr increased prtectin : nging evaluatin Prgress in several areas f translatinal clinical develpment, including investigating IV administratin f attenuated sprzites Past WHO PPC and radmap date back > 5 years. Warrants recnsideratin fr secnd generatin malaria vaccines.
13 Influenza WHO Preferred Prduct Characteristics fr Next-Generatin Influenza Vaccines have been published. Several candidate vaccines designed t elicit antibdies t cnserved epitpes n the hemagglutinin head r stem are advancing t early stage clinical develpment with the gal f achieving brad and durable immunity. BMGF meeting n Influenza Human Challenge Mdel fr universal flu vaccine develpment
14 Entertxigenic E.cli (ETEC) Accrding t the mst recent IHME estimates, ETEC mrtality has declined BUT causes 75 millin episdes f diarrhea each year During VASE 2018, BMGF annunced t phase ut investment in ETEC vaccine develpment due t lwer perceived burden and technical feasibility The leading ETEC vaccine candidate has advanced t a Phase IIb prf-f cncept field study in adult travelers; data expected 2019 Same candidate has cmpleted a phase II study in infants and children in Bangladesh 2017 PDVAC recmmendatin: Develp PPCs and clarity n develpment pathways fr use in LMICs Octber 2017: ETEC Vaccine Preferred Prduct Characteristics (PPCs) February 2018: Jint WHO-NIAID-PATH Wrkshp n develpment and standardizatin f ETEC assays and antigens
15 Shigella Accrding t IHME, Shigella is the secnd mst deadly diarrheal disease. WHO AMR pririty list Clinical pipeline f subunit, live and killed appraches Three next generatin O-Ag based vaccines priritized by BMGF, with a view t understanding hw CHIM can accelerate licensure 2017 PDVAC recmmendatin: Develp PPCs and clarity n develpment pathways fr use in LMICs Octber 2017: Shigella Vaccine Preferred Prduct Characteristics (PPCs) May 2018: WHO Cnsultatin n Prduct develpment and Plicy pathways fr O- antigen based cnjugate Shigella vaccines
16 Respiratry Syncytial Virus (RSV) Prgress in vaccine indicatins fr maternal immunizatin and mnclnal antibdies Lead candidate Ph3 evaluatin prgressing, having successfully passed a futility analysis Multiple gaps identified n the pathway t future implementatin in LMICs Cllabrative platfrm n maternal immunizatin, driven by RSV WHO R&D and technical radmap and PPC available WHO AC set up, wrk expanding fr preparing cnsideratin fr plicy decisin
17 Grup B streptcccus (GBS) Currently tw GBS vaccine candidates underging clinical evaluatin, with several in preclinical develpment. Effrts t characterize f the relatinship between levels f antibdies and prtectin are cntinuing in parallel with cnsultatins regarding an acceptable regulatry rute t licensure and plicy decisin recmmendatins: Pursue effrts t identify a crrelate f prtectin. Evaluate the vaccine value prpsitin cnsidering health, ecnmic and scietal dimensins. WHO PPC and Radmap publically available December 2017: GBS vaccines: the rle f crrelates f prtectin in the pathway t licensure and plicy February 2018: WHO Scientific Advisry Grup t prvide inputs t the develpment f a value prpsitin fr Grup B Streptcccus (GBS) Vaccine
18 Grup A streptcccus (GAS) New burden estimates: An estimated 18 millin peple suffer frm a serius GAS disease, and 1.8 millin new cases and 517,000 deaths ccur annually. The greatest burden is due t rheumatic heart disease, but invasive GAS diseases (including maternal and nenatal sepsis) als cntribute significantly 2018 WHA reslutin n Rheumatic Fever and Rheumatic Heart Disease 2017 recmmendatins: Evaluate the vaccine value prpsitin cnsidering health, ecnmic and scietal dimensins. WHO PPC and Radmap publically available May 2018: WHO Cnsultatin n GAS vaccine research and develpment Renewed cnsensus develpment pathway, active cllabratins n the value prpsitin
19 Herpes Simplex Virus (HSV) Prphylactic HSV2 vaccines are preferred fr LMICs, but current clinical candidates being tested as therapeutic vaccines Therapeutic vaccines have demnstrated clinical POC, but have nt prgressed Therapeutic HSV2 candidates culd have ppulatin impact in LMICS if able t reduce HSV2 transmissin and/r HIV acquisitin, as well as GUD Need t articulate strng value prpsitins fr prphylactic and therapeutic HSV vaccines in LMICs HSV PPC drafted Several activities underway t strengthen the full public health value f HSV vaccines Estimates f HSV GUD, HSV-2-assciated HIV, HSV-1 utcmes HSV ecnmic burden HSV vaccine impact mdeling
20 Nucleic acid vaccine (NAVs) platfrms Advances in the in viv expressin, stabilizatin and delivery f bth RNA and DNA have imprved the prspects fr immunizatin by NAVs. Increasingly, NAV vaccines are cnsidered t be a ptential game changer fr epidemic and pandemic respnse due t the expectatin that they may be significantly faster and cheaper t manufacture, simpler t administer, and ptentially mre effective than cnventinal vaccines. WHO Cnsultatin held t determine whether the existing DNA guidelines were due fr revisin r if they remained relevant with tday s status f nucleic acid vaccine develpment and maturity twards licensure February 2018: Prduct develpment and prgrammatic cnsideratins fr nucleic acid based vaccines & WHO Cnsultatin n Nucleic acid vaccine guidelines
21 Micrarray patch prduct develpment fr MR vaccines Recmmendatin by SAGE, Octber 2016: SAGE acknwledged the imprtance f peratinal and technlgical research t address the barriers t achieving GVAP [Glbal Vaccine Actin Plan] measles and rubella gals. In particular, SAGE recmmended that the mst expeditius clinical develpment and regulatry pathway t licensure f measles cntaining vaccines (MCV) micr-array patch (MAP) be determined, and that barriers t the develpment, licensure, and use f MAPs fr measles and rubella vaccine delivery be identified and addressed urgently. March 2018: Measles cntaining vaccines (MCV) Micrarray Patch (MAP) prduct develpment
22 Nvel appraches t priritize vaccine innvatins t imprve cverage and equity Vaccine cverage fr rutine vaccines has failed t reach the glbal targets f 90% using current delivery strategies. Develpment and uptake f nvel vaccines, delivery appraches and delivery technlgies are needed t reach the immunizatin targets
23 Nvel appraches t priritize vaccine innvatins t imprve cverage and equity Gavi, WHO, Unicef, PATH and BMGF are wrking tgether t develp tw new tls t identify and priritise high impact innvatins that meet the preferences and pririties f lw and middle incme cuntries Ttal Systems Effectiveness (TSE) is a hlistic apprach t evaluate and priritize vaccine innvatins, by cnsidering their ptential t increase the cverage and t infrm nvel vaccine innvatins thrugh Vaccine Innvatin Priritizatin Strategy (VIPS).
24 WHO versight and guidance f vaccine prduct develpment and intrductin Early-stage value prpsitin Late-stage value prpsitin Discvery WHO Regist Implement Preclinical Phase I Phase II Phase III plicy F&P Uptake ratin n studies & PQ PDVAC: Early stage (pre-phase II POC) IVIR-AC: Plicy preparatin & decisin-making IPAC PQ SAGE PDVAC: Prduct Develpment fr Vaccines Advisry Cmmittee IVIR-AC: Immunizatin and Vaccines-related Implementatin Research Advisry Cmmittee IPAC: Immunizatin Practices Advisry Cmmittee SAGE: Strategic Advisry Grup f Experts n Immunizatin PSPQ: Prequalificatin
25 Glbal Vaccine and Immunizatin Research Frum (GVIRF) Bangkk, March 2018 C-hsted by WHO, the Natinal Institute f Allergy and Infectius Diseases, and the Bill & Melinda Gates Fundatin. All research aspects related t the Glbal Vaccine Actin Plan (GVAP) Pathgen and crss-cutting tpics such as expanding and leveraging DCVMs, maternal and adlescent immunizatin platfrms, innvating fr equity Tracks prgress, identifies gaps, creates alignment and crdinates activities t increase the efficiency and impact f activities and resurces.
26 References Generic Preferred Prduct Prfile fr Vaccines (gppp) Assessing the prgrammatic suitability f vaccine candidates fr WHO prequalificatin (Revisin 2014) IVR vaccine PPCs and Radmaps:
State Health Improvement Plan Choosing Priorities, Creating a Plan. DHHS DPH - SHIP Priorities (Sept2016) 1
State Health Imprvement Plan 2017-2021 Chsing Pririties, Creating a Plan DHHS DPH - SHIP Pririties (Sept2016) 1 Creating a Plan: 2017-2021 SHIP Welcme! Wh s here? What is the State Health Imprvement Plan
More informationImplementation of G6PD testing and radical cure in P. vivax endemic countries: considerations
Implementatin f G6PD testing and radical cure in P. vivax endemic cuntries: cnsideratins Malaria Plicy Advisry Cmmittee Geneva, Switzerland 16-18 September 2015 1 WHO Guidelines n Radical Cure WHO guidelines
More informationVCCC Research and Education Lead for Breast Cancer
VCCC Research & Educatin Lead VCCC Research and Educatin Lead fr VCCC Visin The Victrian Cmprehensive Cancer Centre (VCCC) will save lives thrugh the integratin f cancer research, educatin and clinical
More informationStrategic Plan Publication No: EO-SP
Strategic Plan 2017-2019 Publicatin N: EO-SP-170223 +61 2 9036 5002 www.pcg.rg.au pcg.ffice@sydney.edu.au This dcument was prepared by the PCG Executive Office PCG Publicatin number: EO-SP-170223 Psych-nclgy
More informationThe U.S. & The Global Fund to Fight AIDS, Tuberculosis and Malaria
The U.S. & The Glbal Fund t Fight AIDS, Tuberculsis and Malaria The Glbal Fund t Fight AIDS, Tuberculsis and Malaria (Glbal Fund) is an independent, multilateral, financing entity designed t raise significant
More informationPreventing and Responding to Emerging IDs the role of WHO
Preventing and Respnding t Emerging IDs the rle f WHO Mark Jacbs Directr, Divisin f Cmmunicable Diseases WHO Respnding t Emerging Infectius Diseases Sympsium 21st Public Health Summer Schl University f
More informationTrue Patient & Partner Engagement How is it done? How can I do it?
True Patient & Partner Engagement Hw is it dne? Hw can I d it? GROUP TECHNICAL ASSISTANCE JANUARY 18, 2017 COLORADO FOUNDATION FOR PUBLIC HEALTH AND THE ENVIRONMENT Webinar Objectives 1. Describe patient
More information77 WHO/IPA workshop on Immunisation
77 WHO/IPA wrkshp n Immunisatin cst/efficacy f either f them des nt justify their rutine use. Cntents f such diseases shuld be within the respnsibilities f the Epidemilgy Department. XVII INTERNATIONAL
More informationNew London County Unified Intake for Homeless Families
New Lndn Cunty Unified Intake fr Hmeless Families Presentatin by Lisa Tepper Bates, Executive Directr Mystic Area Shelter & Hspitality (MASH) 2011 Snapsht: Family Hmelessness in Sutheastern CT Frm 2010
More informationHospital Preparedness Checklist
Hspital Preparedness Checklist http://pandemicflu.gv Preparedness Subject 1. Structure fr planning and decisin making An internal, multidisciplinary planning cmmittee fr influenza preparedness has been
More informationImproving Surveillance and Monitoring of Self-harm in Irish Prisons
HSE Mental Health Divisin Stewart s Hspital, Palmerstwn, Dublin 20 Tel: 01 6201670 Email: inf@nsp.ie www.nsp.ie Imprving Surveillance and Mnitring f Self-harm in Irish Prisns Prject Scpe Dcument 8 th June
More informationWorld Confederation for Physical Therapy Congress , May Singapore
Wrld Cnfederatin fr Physical Therapy Cngress 2015 1-4, May Singapre Call fr applicatins fr Chair f the Internatinal Scientific Cmmittee The Executive Cmmittee f WCPT invites applicatins and suggestins
More informationWhere do we stand today?
Where d we stand tday? Nte by the United Natins Secretary-General transmitting the reprt f the Directr-General f WHO n the preventin and cntrl f NCDs (10 December 2013) Paragraph 43. Remarkable prgress
More informationUS Public Health Service Clinical Practice Guidelines for PrEP
Webcast 1.3 US Public Health Service Clinical Practice Guidelines fr PrEP P R E S ENTED BY: M A R K T H R U N, M D A S S O C I AT E P R O F E S S O R, U N I V E R S I T Y O F C O L O R A D O, D I V I S
More informationVaccine Impact Modelling Consortium
Vaccine Impact Mdelling Cnsrtium Annual meeting 2017 - Summary meeting reprt Windsr, UK February 28 March 2, 2017 Objectives f the Vaccine Impact Mdelling Cnsrtium The Vaccine Impact Mdelling Cnsrtium
More informationIndependent Charitable Patient Assistance Program (IPAP) Code of Ethics
Independent Charitable Patient Assistance Prgram (IPAP) Cde f Ethics Independent charitable patient assistance prgrams (IPAPs) fcus n the needs f patients wh are insured, meet certain financial limitatin
More informationTERMS OF REFERENCE (ToR) NATIONAL INDIVIDUAL CONSULTANCY
TERMS OF REFERENCE (TR) NATIONAL INDIVIDUAL CONSULTANCY T Develping training materials fr a Human Develpment Mdule Applicatin Type: External vacancy Jb Title: Individual Cnsultancy (IC) Categry: Duty Statin:
More informationPandemic H1N1 2009: DrillSafe Update. David Blizzard BD Manager, Energy Mining and Infrastructure
Pandemic H1N1 2009: DrillSafe Update David Blizzard BD Manager, Energy Mining and Infrastructure Pandemic H1N1 Update CDC.Gv USA Pandemic H1N1 Summary Pints Virus cntinues t spread with nearly all WHO
More informationExclusion of Key Populations and People Living with HIV from implementation of programmes 10 June To: CC:
Exclusin f Key Ppulatins and Peple Living with HIV frm implementatin f prgrammes 10 June 2016 T: CC: Mr. Nrbert Hauser, Chair f the Bard f the Glbal Fund t fight AIDS, TB and Malaria Ms. Aida Kurtvic,
More informationPracticum Evaluation Form - Formative Assessment
Practicum Evaluatin Frm - Frmative Assessment Candidate Name: Candidate ID#: Mentr/Principal Name: LEA/District: Cllege/University: Prgram Crdinatr: This frm is t be cmpleted and frmally shared with the
More informationFrontier School of Innovation District Wellness Policy
Frntier Schl f Innvatin 6700 Crprate dr. Suite 150 Phne: 816-363-1907 http://www.kcfsi.rg/ Frntier Schl f Innvatin District Wellness Plicy The Bard prmtes healthy schls, by supprting wellness, gd nutritin,
More informationAnnual Assembly Abstract Review Process
Annual Assembly Abstract Review Prcess AAHPM and HPNA cllabrate t review and select abstracts fr Annual Assembly. The cmmittees meet prir t the calls t review and update the Assembly bjectives (Planning
More informationSubmitted to the World Health Organisation. Date: 8 th March Contact:
Wrld Cancer Research Fund Internatinal input t the third rund f infrmal cnsultatins n the revised draft WHO glbal actin plan fr the preventin and cntrl f NCDs cvering the perid 2013 t 2020 Submitted t
More informationEXECUTIVE SUMMARY INNOVATION IS THE KEY TO CHANGING THE PARADIGM FOR THE TREATMENT OF PAIN AND ADDICTION TO CREATE AN AMERICA FREE OF OPIOID ADDICTION
EXECUTIVE SUMMARY INNOVATION IS THE KEY TO CHANGING THE PARADIGM FOR THE TREATMENT OF PAIN AND ADDICTION TO CREATE AN AMERICA FREE OF OPIOID ADDICTION The Bitechnlgy Innvatin Organizatin (BIO) and ur member
More informationAppendix B: Action Plan
Appendix B: Access t Care Hw can we ensure equal access t health care services in Pinellas Cunty? Gal AC : Prvide equal access t apprpriate health care services and prviders Plicy Cmpnent (Y/N): N Perfrmance
More informationChildhood Immunization Status (NQF 0038)
Childhd Immunizatin Status (NQF 0038) EMeasure Name Childhd Immunizatin EMeasure Id Pending Status Versin Number 1 Set Id Pending Available Date N infrmatin Measurement Perid January 1, 20xx thrugh December
More informationCFS Private Sector modalities
CFS Private Sectr mdalities APPROVED September 8, 2011 A. BACKGROUND 1. Fd security exists when all peple at all times have physical and ecnmic access t sufficient, safe and nutritius fd t meet their dietary
More informationWCPT awards programme 2015
WCPT awards prgramme 2015 The WCPT awards prgramme recgnises utstanding cntributins and leadership by individual physical therapists and grups t the prfessin and/r glbal health at an internatinal level.
More informationDRIVING A MULTISECTORAL RESPONSE: A DIALOGUE AMONG LEADERS OF UN, MULTILATERAL AGENCIES AND BODIES
FIRST WHO GLOBAL MINISTERIAL CONFERENCE ENDING TB IN THE SUSTAINABLE DEVELOPMENT ERA: A MULTISECTORAL RESPONSE WORLD TRADE CENTER MOSCOW, RUSSIAN FEDERATION 16 17 NOVEMBER 2017 THIRD HIGH-LEVEL PLENARY
More informationCampus Climate Survey
Campus Climate Survey Executive Summary www.ecu.edu/ecyu 2016 A prject spnsred by the Office fr Equity and Diversity Executive Summary Prject Backgrund In FY 2013-2014, the Campus Climate Cmmissin prpsed
More informationCall Summary. The following conference events focused on female condoms:
Call Summary Presentatin: Serra Sippel, president, Center fr Health and Gender Equity (CHANGE): Debriefing n Female Cndm Activities at the XVII Internatinal AIDS Cnference The attentin and activities devted
More informationACSQHC National Consensus Statement: Essential Elements for High Quality End-oflife Care in Acute Hospitals.
27 March 2014 Prfessr Debra Picne Chief Executive Officer Australian Cmmissin n Safety and Quality in Health Care c/ Ms Jennifer Hill, Senir Prject Officer Level 5, 255 Elizabeth Street SYDNEY NSW 2000
More informationModule 6: Goal Setting
Mdule 6: Gal Setting Objectives T understand the cncept f gal setting in Brief CBT T acquire skills t set feasible and apprpriate gals in Brief CBT What is gal setting, and why is it imprtant t set gals
More informationImplementation of Early retention monitoring of HIV positive pregnant and breastfeeding women; and data use in the EMTCT program MOH-UGANDA
Implementatin f Early retentin mnitring f HIV psitive pregnant and breastfeeding wmen; and data use in the EMTCT prgram MOH-UGANDA Presentatin utline Backgrund Methdlgy Issues addressed Challenges identified
More informationGuidance for Applicants to the Global fund to Fight AIDS, TB and Malaria Round 8 Call for proposals 28 February 2008
Guidance fr Applicants t the Glbal fund t Fight AIDS, TB and Malaria Rund 8 Call fr prpsals 28 February 2008 Sexual Minrities Backgrund: The bard f the Glbal Fund t Fight AIDS, TB and Malaria at its 16
More information1 st Pan-African Youth SUMMIT - Youth#EndFGM2018
1 st Pan-African Yuth SUMMIT - Yuth#EndFGM2018 YOUNG PEOPLE ARE THE HEART AND SOUL OF THE END FGM MOVEMENT 25 26 th April 2018, Nairbi The Girl Generatin is pleased t annunce the first ever Pan-African
More informationProduct Development for Vaccines Advisory Committee:
Product Development for Vaccines Advisory Committee: Highlights from the 2016 year of vaccine development SAGE, October 2016 David C. Kaslow, MD Chair, Product Development for Vaccines Advisory Committee
More informationResponse to. type 2 vaccine-derived polioviruses. prior to global topv withdrawal. Interim Guidelines
Respnse t type 2 vaccine-derived pliviruses prir t glbal topv withdrawal Interim Guidelines August 2015 GPEI peratinal guidance nte August 2015 Summary Prepare fr prmpt actin fr any area r ppulatin at
More informationNovel methods and approaches for sensing, evaluating, modulating and regulating mood and emotional states.
Nvel methds and appraches fr sensing, evaluating, mdulating and regulating md and emtinal states. 2018 Jy Academic Grant Call fr Prpsals Intrductin The Annual Jy grant initiative aims t prmte and cntribute
More informationFull-time or part-time to a minimum of 0.8FTE (30 hours per week) Job Reference: CLS00161
Jb Title: Medical Statistician Grade: 8 Salary: 42,418 t 47,722 per annum Department: Research Design Service (RDS) and Leicester Clinical Trials Unit (LCTU) Cntract: Open ended cntract subject t fixed
More informationAssessment Field Activity Collaborative Assessment, Planning, and Support: Safety and Risk in Teams
Assessment Field Activity Cllabrative Assessment, Planning, and Supprt: Safety and Risk in Teams OBSERVATION Identify a case fr which a team meeting t discuss safety and/r safety planning is needed r scheduled.
More informationPosition Title Diabetes Educator Program / Funding Stream Primary Health Care
P O S I T I O N P R O F I L E POSITION TITLE: Diabetes Educatr Psitin Title Diabetes Educatr Prgram / Funding Stream Primary Health Care Psitin Classificatin RAHP Leve 4 - Level 5 r NUR Level 3 - Level
More informationRegulatory forum for manufacturers
Cllabrative Registratin Prcedure fr Advancing Vaccines Cllabrative Registratin in Prcedure fr Advancing Vaccines Emerging Registratin Cuntries in Emerging Cuntries 19 th Annual General Meeting DCVMN 19
More informationOrganizational Capacity for Change and Patient Safety
Organizatinal Capacity fr Change and Patient Safety Debrah M. Nadzam, PhD, FAAN - Jint Cmmissin Resurces Lrrie Jnes-Hartley, MSN, CRRN-A - Durham Reginal Hspital Presentatin Objectives Briefly describe
More informationMINISTRY OF HEALTH INFORMATION BRIEFING NOTE
Cliff # 980489 MINISTRY OF HEALTH INFORMATION BRIEFING NOTE. PREPARED FOR: Graham Whitmarsh, Deputy Minister, Ministry f Health Heather Davidsn, ADM, Planning and Innvatin Divisin FOR INFORMATION TITLE:
More informationCHAI Update, February 2013
https://wikileaks.rg/pdesta-emails/emailid/31276 GLOBAL PROGRAM S CHAI UPDATE February2013 Essential Medicines/zinc/ORS CHAI secured $9 millin USD frm NORAD/the Gvernment f Nrway t supprt its zinc-ors
More informationSwindon Joint Strategic Needs Assessment Bulletin
Swindn Jint Strategic Needs Assessment Bulletin Swindn Diabetes 2017 Key Pints: This JSNA gives health facts abut peple with diabetes r peple wh might get diabetes in Swindn. This helps us t plan fr medical
More informationFOUNDATIONS OF DECISION-MAKING...
Table f Cntents FOUNDATIONS OF DECISION-MAKING... Errr! Bkmark nt Describe the decisin-making prcess pp.62-66... Errr! Bkmark nt Explain the three appraches managers can use t make decisins pp.67-70 Errr!
More informationARLA FOOD FOR HEALTH 4 th ANNUAL CALL FOR EXPRESSIONS OF INTEREST
ARLA FOOD FOR HEALTH 4 th ANNUAL CALL FOR EXPRESSIONS OF INTEREST 7 th July 2017 Cntent 1 Intrductin 2 Tpics fr EOI in the 4 th call 3 The applicatin prcess and imprtant dates 4 Guideline fr EOIs Deadline
More informationAUTHORISED BY: CEO. Introduction. Whistle Blowing
GUIDELINE NAME: Field Cmplaints Disclsure Guidelines SECTION : Refer t Excel Guidelines list Dcument N: DISTRIBUTION: All Emplyees FIRST ISSUED: April 2013 DATE UPDATED: Dec 2014 ISSUED/UPDATED BY: Peple
More informationBritish Sign Language (BSL) Plan October 2018 Scottish Charity Regulator
British Sign Language (BSL) Plan 2018-2024 Octber 2018 Scttish Charity Regulatr Cntents Sectin 1: Intrductin and cntext 1.1 Intrductin 1.2 Our wrk and what we d Sectin 2: Our BSL Plan 2.1 Scttish Public
More informationOntario s Approach to Federal Cannabis Legalization
Ontari s Apprach t Federal Cannabis Legalizatin Ontari s Key Areas f Fcus Ontari s regulatry apprach will align with the federal gvernment s legislative framewrk (see Appendix fr further detail n federal
More informationImpacts of State Level Dental Hygienist Scope of Practice on Oral Health Outcomes in the U.S. Population
Impacts f State Level Dental Hygienist Scpe f Practice n Oral Health Outcmes in the U.S. Ppulatin Building Trust in Peple and Places C-spnsred by: Prfessinal Standards Authrity Centre fr Trust, Peace and
More informationChildhood Immunization Status (NQF 0038)
Childhd Immunizatin Status (NQF 0038) EMeasure Name Childhd Immunizatin EMeasure Id Pending Status Versin Number 1 Set Id Pending Available Date N infrmatin Measurement Perid January 1, 20xx thrugh December
More informationCatherine Worthingham Fellows of APTA Instructions for Writing a Letter of Support
Catherine Wrthingham Fellws f APTA Instructins fr Writing a Letter f Supprt Fllwing is infrmatin designed t assist persns asked t write a letter f supprt fr a nminee fr the American Physical Therapy Assciatin
More informationReliability and Validity Plan 2017
Reliability and Validity Plan 2017 Frm CAEP The principles fr measures used in the CAEP accreditatin prcess include: (a) validity and reliability, (b) relevance, (c) verifiability, (d) representativeness,
More informationMedical Director of Palliative Care INFORMATION PACK
Medical Directr f Palliative Care INFORMATION PACK CONTENTS: Selectin Criteria (please address in a cver letter) & Hw T Apply Cntext and Scpe HammndCare s Mtivatin, Missin and Missin in Actin (ur cre values)
More informationPrimary Health Networks Greater Choice for At Home Palliative Care Central Queensland Wide Bay Sunshine Coast PHN
Primary Health Netwrks Greater Chice fr At Hme Palliative Care Central Queensland Wide Bay Sunshine Cast PHN Dcument cntrl 1 1. Planned activities funded under the Activity Primary Health Netwrks Greater
More informationA pre-conference should include the following: an introduction, a discussion based on the review of lesson materials, and a summary of next steps.
NAU Mdel Observatin Prtcl The mdel prtcl was develped with supprt and expertise frm the Natinal Institute fr Excellence in Teaching (NIET) and is based in great part n NIET s extensive experience cnducting
More informationTASKFORCE REPORT AIMS TO BOOST CANCER SURVIVAL AND TRANSFORM PATIENT EXPERIENCE
Sunday 19 July, 2015 TASKFORCE REPORT AIMS TO BOOST CANCER SURVIVAL AND TRANSFORM PATIENT EXPERIENCE SIX STRATEGIC pririties have tday (Sunday) been recmmended by the Independent Cancer Taskfrce t help
More informationMalaria 2025: Accelerate to Eliminate The Global Technical Strategy for Malaria: Setting global targets Azra Ghani, GTS Steering Committee
Malaria 2025: Accelerate t Eliminate The Glbal Technical Strategy fr Malaria: 2016-2025 Setting glbal targets Azra Ghani, GTS Steering Cmmittee Geneva, 12 March 2014 1 Visin and Gals Purpse f Visin and
More informationHSC 106 Personal Health Plan for Learning Activities & Assessment linked to Michigan Teacher Preparation Standards
HSC 106 Persnal Health Plan fr Learning Activities & Assessment linked t Michigan Teacher Preparatin Standards Standard 1 Cmpetency 1.1 Understand basic health cntent as it relates t schl health educatin.
More informationSTAKEHOLDER IN-DEPTH INTERVIEW GUIDE
STAKEHOLDER IN-DEPTH INTERVIEW GUIDE PURPOSE The Stakehlder In-Depth Interview Guide cntributes t understanding the scale-up prcess by asking key stakehlders t evaluate what has been achieved in scaleup,
More informationneuropharmaceuticals commericalization
neur neurpharmaceuticals cmmericalizatin neurnan pharma 11th Annual NanBusiness Cnference Nanmanufacturing Summit September 4-6, 2012 Bstn, MA neur I. Intrductin 2 Alexander Kabanv, C-funder UNC - Chapel
More informationConcept paper on the need for revision of the guideline on clinical investigation of medicinal products in the treatment of depression
1 2 3 10 Nvember 2016 EMA/CHMP/183826/2016 Cmmittee fr Medicinal Prducts fr Human Use (CHMP) 4 5 6 7 Cncept paper n the need fr revisin f the guideline n clinical investigatin f medicinal prducts in the
More informationCommissioning Policy: South Warwickshire CCG (SWCCG)
Cmmissining Plicy: Suth Warwickshire CCG (SWCCG) Treatment Indicatin Criteria FreeStyle Libre Flash Cntinuus Glucse Mnitring System Type I Diabetes Prir apprval must be requested frm the Individual Funding
More informationMalaria 2025: Accelerate to Eliminate The Global Technical Strategy for Malaria:
Malaria 2025: Accelerate t Eliminate The Glbal Technical Strategy fr Malaria: 2016-2025 Prcess t date and structure Pedr Alns, GTS Steering Cmmittee Chair Geneva, 12 March 2014 1 Audience and purpse f
More informationStructured Assessment using Multiple Patient. Scenarios (StAMPS) Exam Information
Structured Assessment using Multiple Patient Scenaris (StAMPS) Exam Infrmatin 1. Preparing fr the StAMPS assessment prcess StAMPS is an assessment mdality that is designed t test higher rder functins in
More informationHealth Consumers Queensland submission
Health Cnsumers Queensland submissin Inquiry int Public Health (Medicinal Cannabis) Bill 2016 Queensland Parliament Health, Cmmunities, Disability Services and Family Vilence Preventin Cmmittee Cntact:
More informationLEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST
OPTUM LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY / APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED
More informationREQUEST FOR EXPRESSIONS OF INTEREST: RETHINK HIV GRAND CHALLENGE. Terms of Reference
REQUEST FOR EXPRESSIONS OF INTEREST: RETHINK HIV GRAND CHALLENGE Terms f Reference The United States Agency fr Internatinal Develpment (USAID) and the Natinal AIDS Cntrl Organizatin (NACO) have launched
More informationPennsylvania Guidelines on the Use of Opioids to Treat Chronic Noncancer Pain
Pennsylvania Guidelines n the Use f Opiids t Treat Chrnic Nncancer Pain Chrnic pain is a majr health prblem in the United States, ccurring with a pintprevalence f abut ne-third f the US ppulatin.(1) Mre
More informationPediatric and adolescent preventive care and HEDIS *
Pediatric and adlescent preventive care and HEDIS * * HEDIS is a registered trademark f the Natinal Cmmittee fr Quality Assurance (NCQA). UniCare Health Plan f West Virginia, Inc. Healthcare Effectiveness
More informationBreast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)
Breast Cancer Awareness Mnth 2018 Key Messages (as f June 6, 2018) In this dcument there are tw sectins f messages in supprt f Cancer Care Ontari s Breast Cancer Awareness Mnth 2018: 1. Campaign key messages
More informationPromoting Health and Preventing Disease: The EU Health Promotion and Disease Prevention Knowledge Gateway
Prmting Health and Preventing Disease: The EU Health Prmtin and Disease Preventin Knwledge Gateway Stefan Strcksdieck genannt Bnsmann n behalf f Petrs A. Maragkudakis, Ianna Bakgianni, Susanne Safkan,
More informationStatement of Work for Linked Data Consulting Services
A. Backgrund Infrmatin Statement f Wrk fr Linked Data Cnsulting Services The Natinal Library f Medicine (NLM), in Bethesda, Maryland, is a part f the Natinal Institutes f Health, US Department f Health
More informationMeeting the Nutritional Requirements of Individuals with Dementia
Unit 15: Understanding and Meeting the Nutritinal Requirements f Individuals with Dementia Unit reference number: D/616/7124 Level: 3 Unit type: Optinal Credit value: 3 Guided learning hurs: 26 Unit summary
More informationAppendix C. Master of Public Health. Practicum Guidelines
Appendix C Master f Public Health Practicum Guidelines 0 Gergia State University, Schl f Public Health Master f Public Health Practicum Guidelines Fr mre infrmatin, cntact Jessica Hwell Pratt, MPH Practicum
More informationCode of Conduct for Employees
Crprate Human Resurces Plicy Cntent Updated: 2016-06-22 Wrk Envirnment Plicy N: HR-01-09 Page 1 f 5 Apprval: 2014-09-24 Cde f Cnduct fr Emplyees POLICY STATEMENT The residents and businesses f the City
More informationTOR- GIPA PROJECT FINAL EVALUATION
1. BACKGROUND TOR- GIPA PROJECT FINAL EVALUATION 1.1. Backgrund t the UNV Prgramme The United Natins Vlunteer (UNV) prgramme is the UN rganizatin that cntributes t peace and develpment thrugh vlunteerism
More informationYear 10 Food Technology. Assessment Task 1: Foods for Special Needs. Name: Teacher:
Year 10 Fd Technlgy Assessment Task 1: Fds fr Special Needs Name: Teacher: Due Date: Term 2, Week 1 Type f Task: Design Task Planning Fd Requirements Cllectin f Assessment: Submit in Class Assessment Plicy:
More informationCatherine Worthingham Fellows of the APTA Instructions for Nominators
Catherine Wrthingham Fellws f the APTA Instructins fr Nminatrs The fllwing infrmatin was prepared t aid nminatrs in making a nminatin fr the APTA membership categry f Catherine Wrthingham Fellw. Please
More informationDiabetes Canada Pre-Budget Consultation Submission. Standing Committee on Finance and Economic Affairs. Government of Ontario.
Diabetes Canada 2018 Pre-Budget Cnsultatin Submissin Standing Cmmittee n Finance and Ecnmic Affairs Gvernment f Ontari January 17, 2018 1 Executive Summary Tday, abut 4.4 millin Ontarians, r 29 per cent
More informationLancet Special Issue on HIV in Men who have Sex with Men (MSM)
Lancet Special Issue n HIV in Men wh have Sex with Men (MSM) July 2012 Summary Pints fr Plicy Makers Executive Summary The Lancet MSM and HIV series shw us that HIV epidemics amng MSM are fundamentally
More informationDRAFT EMEA PANDEMIC INFLUENZA CRISIS MANAGEMENT PLAN FOR THE EVALUATION AND MAINTENANCE OF PANDEMIC INFLUENZA VACCINES AND ANTIVIRALS
Eurpean Medicines Agency Lndn, 14 Nvember 2005 Dc. Ref. EMEA/397403/2005 DRAFT EMEA PANDEMIC INFLUENZA CRISIS MANAGEMENT PLAN FOR THE EVALUATION AND MAINTENANCE OF PANDEMIC INFLUENZA VACCINES AND ANTIVIRALS
More informationNew Guidance & Technical Specifications. Dr Ute Ströher, Technical Officer, IVD Assessment
New Guidance & Technical Specificatins Dr Ute Ströher, Technical Officer, IVD Assessment Cpenhagen, Denmark 24 27 September 2018 1 Guidance fr manufacturers Develped by the WHO Prequalificatin Team Diagnstic
More informationAgenda Item 3 CX/FL 17/44/3 Add 1 September 2017
E Agenda Item 3 CX/FL 17/44/3 Add 1 September 2017 1. Intrductin JOINT FAO/WHO FOOD STANDARDS PROGRAMME CODEX COMMITTEE ON FOOD LABELLING 44 th Sessin Asunción, Paraguay, 16 20 Octber 2017 DISCUSSION PAPER
More informationMINISTERIAL PARALLEL PANEL TOWARDS TB ELIMINATION IN LOW-INCIDENCE COUNTRIES
FIRST WHO GLOBAL MINISTERIAL CONFERENCE ENDING TB IN THE SUSTAINABLE DEVELOPMENT ERA: A MULTISECTORAL RESPONSE WORLD TRADE CENTER MOSCOW, RUSSIAN FEDERATION 16 17 NOVEMBER 2017 MINISTERIAL PARALLEL PANEL
More informationService Change Process. Gateway 1 High-level Proposition. Innovation project name: Patient Self-Monitoring/Management of Warfarin
Service Change Prcess Gateway 1 High-level Prpsitin Innvatin prject name: Patient Self-Mnitring/Management f Warfarin NHS Bury Please describe the service change being prpsed. Please describe what service(s)
More informationActivating the patient s immune system to fight. system to. Company presentation. fight cancer. Company presentation. August November
Activating the patient s the immune system t fight immune cancer system t Cmpany presentatin fight cancer Cmpany presentatin August Nvember 2018 2018 IMPORTANT NOTICE AND DISCLAIMER This reprt cntains
More informationTB/HIV in the Americas Review of Progress, Barriers and Successes
TB/HIV in the Americas Review f Prgress, Barriers and Successes Dr. Massim N Ghidinelli Unit Chief HIV, Hepatitis, TB and STI Pan American Health Organizatin 19 th Cre Grup Meeting f the Glbal TB/HIV Wrking
More informationTELCOMMUNICATIONS CONSUMER PROTECTIONS CODE (C628:2012) EXPLANATORY STATEMENT
TELCOMMUNICATIONS CONSUMER PROTECTIONS CODE (C628:2012) EXPLANATORY STATEMENT Intrductin This is the Explanatry Statement fr the revised Cmmunicatins Alliance Telecmmunicatins Cnsumer Prtectins (TCP) Industry
More informationHepCAP: Hepatitis C Allies of Philadelphia February 2012: Meeting Highlights
HepCAP: Hepatitis C Allies f Philadelphia February 2012: Meeting Highlights On February 1, 2012 seventy-tw peple representing ver thirty agencies came tgether at the Philadelphia Department f Public Health
More informationThis clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.
abcd Clinical Study Synpsis fr Public Disclsure This clinical study synpsis is prvided in line with Behringer Ingelheim s Plicy n Transparency and Publicatin f Clinical Study Data. The synpsis which is
More informationAttachment 3. Efforts to Address the Opioid Epidemic in Clark County
Attachment 3 Effrts t Address the Opiid Epidemic in Clark Cunty Overview Backgrund Current wrk SNHD Challenges Next Steps Backgrund Drug verdses are nw the leading cause f death amng Americans under 50
More informationInternational Experts Meeting on Severe Accident Management in the Light of the Accident at the Fukushima Daiichi Nuclear Power Plant
IAEA-CN-233 Internatinal Experts Meeting n Severe Accident Management in the Light f the Accident at the Fukushima Daiichi Nuclear Pwer Plant Organized in cnnectin with the implementatin f the IAEA Actin
More informationVaccine Information Statement: LIVE INTRANASAL INFLUENZA VACCINE
Vaccine Infrmatin Statement: LIVE INTRANASAL INFLUENZA VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están
More informationRisk factors in health and disease
Risk factrs in health and disease Index 1 Intrductin 2 Types f risk factrs 2.1 Behaviural risk factrs 2.2 Psychlgical risk factrs 2.3 Demgraphic risk factrs 2.4 Envirnmental risk factrs 2.5 Genetic risk
More informationEpidemic Planet. Interactively visualizing and comparing epidemic simulations.
Epidemic Planet Interactively visualizing and cmparing epidemic simulatins. Exhibit descriptin - summary Title f the exhibitin: Epidemic Planet Abstract A better understanding and mre accurate frecasting
More informationPublic consultation on the NHMRC s draft revised Australian alcohol guidelines for low-risk drinking
Public cnsultatin n the NHMRC s draft revised Australian alchl guidelines fr lw-risk drinking Recmmendatins frm The Cancer Cuncil Australia The Cancer Cuncil Australia is Australia s peak nn-gvernment
More information